Directory: Developing World Health Partnerships
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
September 2012
Now totaling 220 and reaching people in more than 160 countries, these health partnerships highlight the commitment of research-based pharmaceutical industry and its many partners including governments, intergovernmental organizations, nongovernmental organizations, private sector companies and universities to improve health around the world.
The launch of this directory coincides with the release of an independent review of the contributions these health partnerships’ make to the health of people in low- and middle-income countries. This review was conducted by BSR, a global business network and consultancy focused on sustainability.
“Global health issues are complex, and solutions often require a range of organizations working together,” said Eduardo Pisani, IFPMA Director General. “Understanding the value of partnerships, our industry and partners have increased these programs dramatically in recent years as highlighted in our directory. This year, we are pleased that BSR analyzed these programs and made suggestions for increasing the benefit people in developing countries.”
The industry-led health partnerships catalogued in the IFPMA’s Developing World Health Partnerships Directory focus on a wide range of activities from developing new treatments and improving their availability to strengthening health systems, raising awareness, prevention and training. They also cover various types of diseases such as HIV/AIDS, neglected tropical diseases, malaria, non-communicable diseases and more cross-cutting challenges such as women and children’s health.
Developing World Health Partnerships Directory or BSR’s review can be found at: http://partnerships.ifpma.org/
vaccines and global health :: ethics and policy 